[
  {
    "ts": "2025-08-08T12:14:00+00:00",
    "headline": "ACHV: Second Quarter Results",
    "summary": "By John Vandermosten, CFA NASDAQ:ACHV READ THE FULL ACHV RESEARCH REPORT Achieve Life Sciences, Inc. (NASDAQ:ACHV) reported its second quarter 2025 results and highlighted several milestones achieved since the last quarterly update. This includes forging a partnership with Omnicom for launching cytisinicline, submitting the New Drug Application (NDA), generating necessary safety exposure data for",
    "url": "https://finance.yahoo.com/news/achv-second-quarter-results-121400473.html",
    "source": "Zacks Small Cap Research",
    "provider": "yfinance",
    "raw": {
      "id": "5a2b2b4c-8a76-38ec-8fec-1102421c6bad",
      "content": {
        "id": "5a2b2b4c-8a76-38ec-8fec-1102421c6bad",
        "contentType": "STORY",
        "title": "ACHV: Second Quarter Results",
        "description": "",
        "summary": "By John Vandermosten, CFA NASDAQ:ACHV READ THE FULL ACHV RESEARCH REPORT Achieve Life Sciences, Inc. (NASDAQ:ACHV) reported its second quarter 2025 results and highlighted several milestones achieved since the last quarterly update. This includes forging a partnership with Omnicom for launching cytisinicline, submitting the New Drug Application (NDA), generating necessary safety exposure data for",
        "pubDate": "2025-08-08T12:14:00Z",
        "displayTime": "2025-08-08T12:14:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/scr.zacks.com/9b049a62c915d6d928fd26cdbc9b051d",
          "originalWidth": 2158,
          "originalHeight": 854,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aZ0bLi0VKh67_pLs2ng.jA--~B/aD04NTQ7dz0yMTU4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/scr.zacks.com/9b049a62c915d6d928fd26cdbc9b051d.cf.webp",
              "width": 2158,
              "height": 854,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aPUqZExPCw_5SGrgJ3UB5A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/scr.zacks.com/9b049a62c915d6d928fd26cdbc9b051d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks Small Cap Research",
          "url": "http://scr.zacks.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/achv-second-quarter-results-121400473.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/achv-second-quarter-results-121400473.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ACHV"
            },
            {
              "symbol": "OMC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]